154 related articles for article (PubMed ID: 35892971)
1. The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma.
Huang K; Wang H; Xu J; Xu R; Liu Z; Li Y; Xu Z
Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892971
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of TPM1-4 in hepatocellular carcinoma.
Tian Z; Zhao J; Wang Y
Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
[TBL] [Abstract][Full Text] [Related]
3. Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer.
Yan Y; Li J; Ye M; Li Z; Li S
Dis Markers; 2022; 2022():6936262. PubMed ID: 35734544
[TBL] [Abstract][Full Text] [Related]
4. Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma.
Huang K; Xu H; Han L; Xu R; Xu Z; Xie Y
Front Mol Biosci; 2022; 9():1054614. PubMed ID: 36699699
[No Abstract] [Full Text] [Related]
5. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma.
Li Y; Zhang Y; Wu Z; Sun P
BMC Neurol; 2023 Jan; 23(1):17. PubMed ID: 36639743
[TBL] [Abstract][Full Text] [Related]
7.
Xu L; Liu Z; Wang H; Lu J; Xu J; Meng Y; Huang K; Liu B
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980973
[TBL] [Abstract][Full Text] [Related]
8. TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas.
Tao T; Shi Y; Han D; Luan W; Qian J; Zhang J; Wang Y; You Y;
Tumour Biol; 2014 Sep; 35(9):9053-9. PubMed ID: 24913705
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
10. High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma.
Zhang F; Cai HB; Liu HZ; Gao S; Wang B; Hu YC; Cheng HW; Liu JX; Gao Y; Hong WM
Dis Markers; 2022; 2022():8133505. PubMed ID: 35493303
[TBL] [Abstract][Full Text] [Related]
11. Identification, characterization, and expression of sarcomeric tropomyosin isoforms in zebrafish.
Dube DK; Dube S; Abbott L; Wang J; Fan Y; Alshiekh-Nasany R; Shah KK; Rudloff AP; Poiesz BJ; Sanger JM; Sanger JW
Cytoskeleton (Hoboken); 2017 Mar; 74(3):125-142. PubMed ID: 27998020
[TBL] [Abstract][Full Text] [Related]
12. Muscle type specific expression of tropomyosin isoforms in bovine skeletal muscles.
Oe M; Ohnishi-Kameyama M; Nakajima I; Muroya S; Chikuni K
Meat Sci; 2007 Apr; 75(4):558-63. PubMed ID: 22064019
[TBL] [Abstract][Full Text] [Related]
13. Relationships between tropomyosin and myosin heavy chain isoforms in bovine skeletal muscle.
Oe M; Nakajima I; Muroya S; Shibata M; Chikuni K
Anim Sci J; 2009 Apr; 80(2):193-7. PubMed ID: 20163590
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of beta-tropomyosin (Tpm2) and duplication of the alpha-slow tropomyosin gene (TPM3) in Atlantic salmon Salmo salar.
Silva AMM; Kennedy LS; Hasan SC; Cohen AM; Heeley DH
Comp Biochem Physiol B Biochem Mol Biol; 2020 Jul; 245():110439. PubMed ID: 32283206
[TBL] [Abstract][Full Text] [Related]
15. Sarcomeric TPM3 expression in human heart and skeletal muscle.
Dube DK; Dube S; Abbott L; Elsekaily O; Sanger JW; Sanger JM; Poiesz BJ
Cytoskeleton (Hoboken); 2020 Aug; 77(8):313-328. PubMed ID: 32761805
[TBL] [Abstract][Full Text] [Related]
16. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
Front Genet; 2021; 12():718717. PubMed ID: 34925438
[No Abstract] [Full Text] [Related]
17. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
18. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
19. Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.
Gong Y; Ke Y; Yu Z; Pan J; Zhou X; Jiang Y; Zhou M; Zeng H; Geng X; Hu G
Aging (Albany NY); 2023 Aug; 15(16):8155-8184. PubMed ID: 37602882
[TBL] [Abstract][Full Text] [Related]
20. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
